Print the page
Increase font size
Groundhog Day (Lockdown Edition)

Groundhog Day (Lockdown Edition)

Chris Campbell

Posted August 23, 2023

Chris Campbell

Alex Jones.

The name alone is enough to spark heated debates in homes and social circles across the nation.

It’s synonymous with conspiracy theories, fiery rhetoric, and a style of journalism that is unashamedly provocative.

When Jones speaks, people either seethe… or cheer… or run away… or tiptoe closer with feigned disinterest.

As usual, Jones has stirred the pot yet again…

Igniting a flurry of speculation on Musk's former bird app, X.

And… what if he’s right?

(Broken clocks. Blind squirrels. And all that.)

The Informant!

In case you missed it: 

According to Jones, a “high-level manager in the TSA,” risking much to break rank and step into the light, has confided in him.

The word from the informant? By the time the leaves turn and October graces us, travelers might find themselves once again ensnared in the tangled weave of face masks.

And…

As winter's icy grip approaches, and December takes hold, there may be a return to the all-too-familiar dance of restrictions and lockdowns.

Normally, we’d shrug it off. Claims of “secret whistleblowers” are a dime-a-dozen online.

But, the thing…

The media is indeed ramping up the rhetoric on lockdowns, booster shots, and masks.

To wit:

CNN Tweet

No less, major Hollywood studio Lionsgate… George Morris Brown College… Rutgers University… and more have already announced fresh new mandates.

What if we are in for another round of lockdowns?

Who stands to benefit? What are the paranoids doing to prepare?

And what’s the one “variant-proof” investment that should do well either way?

The Groundhog Day Portfolio

Let’s take a trip down memory lane.

As lockdowns halted travel, astute investors eyed put options on major oil companies, foreseeing a decline in oil demand.

Meanwhile, the heightened demand for personal protective equipment due to lockdowns increased the allure of stocks from key PPE manufacturers.

The global urgency for vaccination thrust pharmaceutical giants into the limelight, particularly as new COVID-19 variants emerged.

The year also marked a pivotal shift towards remote work and telehealth, with companies like Teladoc Health and Zoom becoming integral to this new normal.

But one investment on the “covid 2.0 watchlist” stands out.

By many accounts, it could be poised to succeed regardless.

It’s natural gas.

Extended winter lockdowns boosted the need for heating, favoring investments in natural gas entities. But a cold snap would do that regardless.

Also, since a lot of natural gas travels through the Panama Canal -- which is, of course, experiencing a drought -- that could also push prices up, too.

Should you believe the hype? That’s up to you.

But the point is to win no matter what.

The Silent Killer of Every Portfolio

Posted September 16, 2025

By Chris Campbell

You pick the right stock. You watch it double. You sell. You strut into the bar, pounding your chest… then you watch it go up 10x.

The Outsider’s Guide to 10x

Posted September 15, 2025

By Chris Campbell

This was back when $2 million meant you could buy a mansion in Manhattan and still have enough left over for a butler to press your socks.

How to Become a Pawn Star

Posted September 12, 2025

By James Altucher

I talked to Rick Harrison of Pawn Stars. Here’s why pawn stores are the best businesses ever.

3 Boring Reasons Tokenization Goes to TRILLIONS

Posted September 11, 2025

By Chris Campbell

Don’t think of tokenization as some abstract blockchain thing. Think of it as moving from three buttons to an entire spaceship dashboard.

Nasdaq Tells SEC: “Tokenize Stocks Now!”

Posted September 10, 2025

By Chris Campbell

Six years ago, Nasdaq thought tokenization would start at the edges. Instead, it’s rapidly remaking the core.

Brussels to Beijing: Adapt or Be Dollarized

Posted September 09, 2025

By Chris Campbell

The world’s money is being dragged, kicking and screaming, onto crypto rails. And nobody (NOBODY) is ready for what comes next.